Uncategorized
LensGen secures $21 million in financing for Juvene IOL
LensGen has closed $21 million in Series A financing for Juvene, its modular fluid-optic accommodating IOL, the company announced in a press release.Led by Hoya Group’s corporate investment arm and including funding from Relativity Healthcare partners, the financing includes an option to expand the commitment by $5 million, the release said.